Health Condition 1: null- Essential Hypertension (Zaght al-Dam Qawi Lazimi)
Conditions
Interventions
Intervention1: Tukhm-i Kahu (Oral)
: Tukhm-i Kahu (Sachet containing 5 g fine powder).
Dosage Form: Powder.
Dose: 1 Sachet (5 g) BD ½ hr before breakfast and dinner.
Route of Adminstration: Oral
C
Sponsors
Central Research Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: All subjects will meet the following criteria: 1- Patients of any sex in the age group of 35 to 55 years 2- Patients having Stage-I Hypertension according to JNC-8 (Systolic BP 140-159 and Diastolic BP 90-99 mmHg) with or without the following symptoms: 3- Suda (Headache) 4- Khafaqan (Palpitation) 5- Kasal (Laziness) 6- Qalaq (Anxiety) 7- Usr al-Tanaffus (Breathlessness) 8- Nabz Mumtali (Pulsus plenus) 9- Clinically stable patients 10- Patients not taking any anti-hypertensive drugs 11- Patients willing to sign the informed consent form
Exclusion criteria
Exclusion criteria: Patients will be excluded if they meet any of the following criteria: 1- Patient with SBP >=160 mmHg and DBP >=100 mmHg 2- Patients of Secondary Hypertension 3- Pregnant and Lactating women 4- Obese subjects â?? BMI >30 5- Drug Addicts, Alcoholics 6- Patients not willing to give consent 7- Patients not willing to come for follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Systolic and Diastolic BP from baseline to last follow up Timepoint: On 7th 14th 21st 28th 35th and 42nd day from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-Improvement in Signs and Symptoms of Hypertension 2-Haematological and Biochemical Assessments for Safety 3-Improvement of Quality Life Index Timepoint: On 7th 14th 21st 28th 35th and 42nd day from baseline | — |
Countries
India
Contacts
Public ContactDr Taufiq Ahmad
Central Research Institute of Unani Medicine, Hyderabad
Outcome results
None listed